[EFFECTS OF THYROTROPIC HORMONE AND 1-METHYL-LYSERGIC ACID BUTANOLAMIDE (UML) ON THYROID INHIBITION BY 5-HYDROXYTRYPTAMINE (5-HT))].
D013956:Antithyroid Agents; D007030:Hypothalamo-Hypophyseal System; D008237:Lysergic Acid; D008784:Methysergide; D010600:Pharmacology; D010908:Pituitary Hormones, Anterior; D051381:Rats; D012106:Research; D012701:Serotonin; D013960:Thyroid Function Tests; D013961:Thyroid Gland; D013972:Thyrotropin; D013973:Thyrotropin-Releasing Hormone
D013956:Antithyroid Agents; D010908:Pituitary Hormones, Anterior; D012701:Serotonin; D013973:Thyrotropin-Releasing Hormone; D013972:Thyrotropin; D008237:Lysergic Acid; D008784:Methysergide
EXPERIMENTAL LAB STUDY; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; METHYSERGIDE; PHARMACOLOGY; RATS; SEROTONIN; THYROID GLAND; THYROID GLAND FUNCTION TESTS; THYROTROPIN
EFFETTI DELL'ORMONE TIREOTROPO E DELLA BUTANOLAMIDE DELL'ACIDO 1-METIL-LISERGICO (UML) SULL'INIBIZIONE TIROIDEA DA 5-IDROSSITRIPTAMINA (5-HT)